ABVX Buyout All Cash or With CVR?
The biggest biotech news this week will easily be ABVX and the potential buyout. Just wondering on your thoughts on whether it would be an all cash deal or a deal involving CVR. I know the current CEO has had dealings in the past where he has used CVR in his acquisition deals. But I know that every deal is different and maybe this is one in which the conditions and factors lean toward an all cash deal.
u/limpozzman — 7 hours ago